Magseed Marker included in new SE08 dossier to support localisation funding in France

As of January 2026, the French health authorities have created a new “Safety and Environment Package” for hospitals (Package SE8), which includes the Magseed marker for €390.16 – as outlined in the 2026 Medical Care/Home Hospitalization (MCO/HAD) Service and Tariff Orders published on January 13, 2026 (Order of June 12, 2026, Appendix 11).

This new package, obtained following a rigorous evaluation process to assess the benefit to the healthcare system, removes a major financial barrier to the adoption of wireless localisation.

It will now allow a greater number of patients to benefit from a more comfortable and flexible approach to breast cancer surgery.

As part of this process, the Magseed marker became the first wireless localisation device to receive a favourable opinion from the CNEDiMTS (National Commission for the Evaluation of Medical Devices and Health Technologies), with a Level IV Expected Service Improvement (ASA) rating, obtained in February 2024. 

This remains, to date, the only evaluation of a magnetic marker by experts from the HAS (French National Authority for Health).

Now, after many years of close collaboration with health authorities, it has been determined that the evidence for the effectiveness and value of localisation procedures using the Magseed magnetic marker is unequivocal. 

The SE8 package was created to ensure that the highest level of care is more easily accessible for you and your patients.

Today, the Magseed marker is the most studied wireless localisation system in the world, with over 15,000 patients included in clinical studies and over 500,000 patients treated worldwide. 

Clinical evidence includes the only randomised phase III clinical trial, representing the highest level of data currently available for a wireless localisation technology, and demonstrating extremely low re-excision rates as well as a significant reduction in operating times.

By combining this clinical excellence with the most comprehensive coverage available for a wireless device, we are pleased to continue supporting you in offering the benefits of the Magseed® marker to an ever-increasing number of your patients.

> Click here to discuss implementing the use of the Magseed® marker in your establishment

Magseed® is a trademark of Hologic, Inc. or its subsidiaries in the United States or other countries. 

Intended for medical professionals and use in France only.